We found that BMP-2 modulates AKT phosphorylation (Fig. 6C), but not that of pGSK3β (data not shown), further confirming that in prostate cancer cells β-catenin nuclear signaling is mainly controlled by AKT activity. The gene discussed is AKT1; the disease is Familial prostate cancer.